METabolic EXplorer
Biological chemistry company.
Launch date
Employees
Market cap
AUD10.5m
Enterprise valuation
AUD127m (Public information from Jul 2024)
Share price
€0.1214 METEX.PA
Company register number 423703107
Saint-Beauzire Auvergne-Rhône-Alpes (HQ)
Financials
Estimates*
| EUR | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | 170m | 227m | 132m | 175m | 301m |
| % growth | (89 %) | (86 %) | 339280 % | 34 % | (42 %) | 33 % | 71 % |
| EBITDA | (6.5m) | (10.0m) | (10.2m) | (37.1m) | (24.4m) | (5.4m) | 21.4m |
| % EBITDA margin | (1866 %) | (20006 %) | (6 %) | (16 %) | (18 %) | (3 %) | 7 % |
| Profit | (8.2m) | (8.9m) | 84.1m | (50.8m) | (37.9m) | (26.5m) | (8.2m) |
| % profit margin | (2356 %) | (17864 %) | 50 % | (22 %) | (29 %) | (15 %) | (3 %) |
| EV / revenue | 47.7x | 1247.8x | 1.6x | 0.4x | 0.8x | 0.9x | 0.6x |
| EV / EBITDA | -2.6x | -6.2x | -27.0x | -2.5x | -4.3x | -29.0x | 7.7x |
| R&D budget | 5.5m | 6.1m | 8.1m | 9.8m | - | - | - |
| R&D % of revenue | 1558 % | 12254 % | 5 % | 4 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
€1.5m | Series A | ||
€6.0m | Series B | ||
€5.0m | Series C | ||
| N/A | N/A | IPO | |
| Total Funding | AUD21.3m | ||
Recent News about METabolic EXplorer
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.